Metraipolis › archive › dc_b229170dc03d
Atezolizumab Plus Bevacizumab for Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion: An Inverse Probability of Treatment Weighted Analysis — Europe PMC PMID:41514546
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41514546
- DOI
- 10.3390/cancers18010033
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T11:46:36.194Z
- SHA-256 of the archived text
47afb1abb94e7da2670f293c8980f738507cd72113f9722006bdb7466fef5925- Stable URL of this page
https://metraipolis.com/documento/dc_b229170dc03d
How to cite
Atezolizumab Plus Bevacizumab for Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion: An Inverse Probability of Treatment Weighted Analysis — Europe PMC PMID:41514546 — Europe PMC (en), https://europepmc.org/article/MED/41514546 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b229170dc03d (Metraipolis archive dc_b229170dc03d, sha256 47afb1abb94e7da2670f293c8980f738507cd72113f9722006bdb7466fef5925)
BibTeX
@misc{dcb229170dc03d,
title = {Atezolizumab Plus Bevacizumab for Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion: An Inverse Probability of Treatment Weighted Analysis — Europe PMC PMID:41514546},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41514546},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b229170dc03d; sha256 47afb1abb94e7da2670f293c8980f738507cd72113f9722006bdb7466fef5925},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41514546. Agents can read the archived copy with the MCP tool read_document.